# Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies

> **NCT03680677** · — · RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 20 (estimated)

## Conditions studied

- Leukemia, Acute
- MDS

## Interventions

- **PROCEDURE:** Bone Marrow or Peripheral Blood Graft (BMT)
- **OTHER:** Cancer-directed Therapy or Best Supportive Care
- **DIAGNOSTIC_TEST:** Frailty Assessment

## Key facts

- **NCT ID:** NCT03680677
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-09-21
- **Primary completion:** 2026-06-22
- **Final completion:** 2026-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03680677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03680677, "Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03680677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*